Gro Gausdal
Position
Guest researcher
Affiliation
Publications
Academic article
- Sushil Dhakal; Muntequa Ishtiaq Siraji; Sturla Magnus Grøndal et al. (2026). AXL Kinase Inhibition Promotes Cytosolic DNA Sensor cGAS Activity and Sensitizes Poorly Immunogenic Tumors to Chemo-Immunotherapy. (external link)
- Lars Herfindal; Lene Elisabeth Myhren; Bjørn Tore Gjertsen et al. (2013). Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen. (external link)
- Lene Elisabeth Myhren; Gyrid Nygaard; Gro Gausdal et al. (2013). Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cells. (external link)
- Anna Tutusaus; Estefanía de Gregorio; Blanca Cucarull et al. (2019). A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. (external link)
- Gro Gausdal; Anita Wergeland; Jørn Skavland et al. (2013). Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. (external link)
- Stéphane Terry; Abderemane Abdou; Agnete Svendsen et al. (2019). AXL targeting overcomes human lung cancer cell resistance to NK- And CTL-mediated cytotoxicity. (external link)
- Emily N. Arner; Dina Alzhanova; Jill M. Westcott et al. (2024). AXL-TBK1 driven AKT3 activation promotes metastasis. (external link)
- Gro Gausdal; Bjørn Tore Gjertsen; Kari Espolin Fladmark et al. (2004). Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis. (external link)
- Emmet Martin McCormack; Ingvild Haaland; Gurid Venås et al. (2012). Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. (external link)
- Gro Gausdal; Bjørn Tore Gjertsen; Emmet Martin McCormack et al. (2008). Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death. (external link)
- Dana Bohan; Hanora Van Ert; Natalie Ruggio et al. (2021). Phosphatidylserine receptors enhance SARS-CoV-2 infection. (external link)
- Elise Aasebø; Marc Vaudel; Olav Mjaavatten et al. (2014). Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines. (external link)
- Lea Zoe Landolt; Jessica Furriol; Janka Babickova et al. (2019). AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. (external link)
- Stéphane Terry; Cécile Dalban; Nathalie Rioux-Leclerq et al. (2021). Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade. (external link)
- Zouhair Bouaziz; Samar Issa; Jacques Gentili et al. (2015). Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. (external link)
- Ronja Bjørnstad; Reidun Aesoy; Øystein Bruserud et al. (2019). A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. (external link)
- August Hoel; Tarig Osman; Fredrik Hoel et al. (2021). Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model. (external link)
- Sturla Magnus Grøndal; Anna Tutusaus; Loreto Boix et al. (2024). Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH. (external link)
- Linn Silje Wathne Oftedal; Lene Elisabeth Myhren; Jouni Jokela et al. (2012). The lipopeptide toxins Anabaenolysin A and B target biological membranes in a cholesterol-dependent manner. (external link)
- Agnete Engelsen; Katarzyna Wnuk-Lipinska; Sébastien Bougnaud et al. (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. (external link)
- Maria Lie Lotsberg; Katarzyna Wnuk-Lipinska; Stéphane Terry et al. (2020). AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells. (external link)
- Eric Nguyen; Gro Gausdal; Jacqueline Varennes et al. (2013). Activation of both protein kinase A (PKA) type I and PKA type II isozymes is required for retinoid-induced maturation of acute promyelocytic leukemia cells. (external link)
- Sjur Huseby; Gro Gausdal; Thomas Jeffrey Keen et al. (2011). Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. (external link)
- Olav Tenstad; Eleni Christakou; Linn Hodneland Nilsson et al. (2024). In vivo turnover and biodistribution of soluble AXL: implications for biomarker development. (external link)
- Huiyu Li; Zhida Liu; Longchao Liu et al. (2022). AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1<sup>+</sup> CD8 T cells. (external link)
- Sturla Magnus Grøndal; Magnus Blø; Linn I. H. Nilsson et al. (2024). Targeting AXL cellular networks in kidney fibrosis. (external link)
- Lea Zoe Landolt; Øystein Solberg Eikrem; Philipp Strauss et al. (2017). Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. (external link)
Academic book chapter
Master’s thesis
- Gro Gausdal (1998). Seterettet mutagenese og termostabilitet til isocitrat dehydrogenase fra <EM>Archaeoglobus fulgidus</EM>. (external link)
- Anita Wergeland; Stein Ove Doskeland; Gro Gausdal (2006). Modulating Effects of cAMP and p23 on Daunorubicin induced apoptosis. (external link)
- Nazanin Rouhee; Stein Ove Doskeland; Gro Gausdal (2012). The effect of cyclic AMP on anthracycline induced cell death in vitro and in a transplantable APL NOD/SCID animal model. (external link)
Doctoral thesis (PhD)
- Stefan Hinz; James Lorens; Rolf A. Brekken et al. (2017). Mechanisms of AXL Mediated Cell Plasticity and Drug Resistance. (external link)
- Gro Gausdal; Bjørn Tore Gjertsen; Stein Ove Doskeland (2007). New lessons from an “old” drug: A proteomic study of anthracycline-induced apoptosis in acute myelogenous leukemia. (external link)